Cargando…
Posttransplant Tacrolimus-Induced Diabetic Ketoacidosis: Review of the Literature
Diabetic ketoacidosis (DKA) in patients receiving tacrolimus as part of their immunosuppressive regimen is a rarely reported adverse event. We report a patient with autosomal dominant polycystic kidney disease (ADPKD) and no known history of diabetes mellitus who presented with DKA, 3 months after k...
Autores principales: | Ammari, Zaid, Pak, Stella C., Ruzieh, Mohammed, Dasa, Osama, Tiwari, Abhinav, Jaume, Juan C., Alfonso-Jaume, Maria A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966672/ https://www.ncbi.nlm.nih.gov/pubmed/29854487 http://dx.doi.org/10.1155/2018/4606491 |
Ejemplares similares
-
Randomized Controlled Trial Assessing the Impact of Tacrolimus Versus Cyclosporine on the Incidence of Posttransplant Diabetes Mellitus
por: Torres, Armando, et al.
Publicado: (2018) -
Endobronchial Cartilage Rupture: A Rare Cause of Lobar Collapse
por: Dasa, Osama, et al.
Publicado: (2016) -
Tacrolimus-induced diabetic ketoacidosis with subsequent rapid recovery of endogenous insulin secretion after cessation of tacrolimus: A case report with review of literature
por: Maruyama, Koji, et al.
Publicado: (2019) -
Hyperglycemia in the Posttransplant Period: NODAT vs Posttransplant Diabetes Mellitus
por: Gupta, Suruchi, et al.
Publicado: (2018) -
Posttransplant cyclophosphamide vs tacrolimus–based GVHD prophylaxis: lower incidence of relapse and chronic GVHD
por: Maurer, Katie, et al.
Publicado: (2023)